Clinical Laserthermia Systems
0,391 SEK +4,27 %Vær den første som følger denne virksomhed
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Omsætning
6,27 mio.
EBIT %
-1.075,6 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CLS B
Daglig lav / høj pris
0,375 / 0,45
SEK
Markedsværdi
63,44 mio. SEK
Aktieomsætning
695,46 t SEK
Volumen
1,6 mio.
Finanskalender
Årligt udbytte
22.06.2023
Generalforsamling
29.06.2023
Delårsrapport
25.08.2023
Delårsrapport
17.11.2023
Årsrapport
23.02.2024
Viser Alle indholdstyper